We provide you with 20 years of free, institutional-grade data for BCDA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BCDA. Explore the full financial landscape of BCDA stock.
| Reported Date | CIK | Ticker | Type |
|---|
BioCardia, Inc(NASDAQ:BCDA) 
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmo...
Website: http://www.biocardia.com/
Full Time Employees: 20
CEO: Peter Altman
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about BCDA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.